Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (Q42528478)

1 November 2017

Cholinergic modulation of basal and amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

1 November 2017

0 references

1 reference

Junji Ichikawa

1

1 reference

1 November 2017

Young Chul Chung

2

1 reference

1 November 2017

Zhu Li

3

1 reference

1 November 2017

Jin Dai

4

1 reference

1 November 2017

Herbert Y Meltzer

5

1 reference

1 November 2017

language of work or name

1 reference

1 December 2002

1 reference

1 November 2017

9

1 reference

inferred from page(s)

published in

Brain Research

1 reference

1 November 2017

958

1 reference

1 November 2017

1

1 reference

1 November 2017

176-184

1 reference

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Localization of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Methoctramine moderately improves memory but pirenzepine disrupts performance in delayed non-matching to position test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Increased striatal dopamine efflux follows scopolamine administered systemically or to the tegmental pedunculopontine nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

An M3-like muscarinic autoreceptor regulates the in vivo release of acetylcholine in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Effect of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6-hydroxydopamine-lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Modulation of hippocampal acetylcholine release after fimbria-fornix lesions and septal transplantation in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Elucidating the role of muscarinic receptors in psychosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Pertussis toxin treatment differentially affects cholinergic and dopaminergic receptor stimulation of midbrain dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Facilitation of amphetamine-induced rotation by muscarinic antagonists is correlated with M2 receptor affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Role of the laterodorsal tegmental nucleus in scopolamine- and amphetamine-induced locomotion and stereotypy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic receptors on dopamine terminals in the cat caudate nucleus: Neuromodulation of [3H]dopamine release in vitro by endogenous acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Simultaneous determination of cholecystokinin-like immunoreactivity and dopamine release after treatment with veratrine, NMDA, scopolamine and SCH23390 in rat medial frontal cortex: a brain microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Telenzepine is at least 25 times more potent than pirenzepine--a dose response and comparative secretory study in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Locomotion and stereotypy induced by scopolamine: contributions of muscarinic receptors near the pedunculopontine tegmental nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Coadministration of galanin antagonist M40 with a muscarinic M1 agonist improves delayed nonmatching to position choice accuracy in rats with cholinergic lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Haloperidol increases smoking in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

The dopamine hypothesis of schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Effects of oxotremorine and pilocarpine on striatal acetylcholine release as studied by brain dialysis in anesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Scopolamine prevents the development of sensitization to methamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Scopolamine prevents augmentation of stereotypy induced by chronic methamphetamine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Effects of selective muscarinic antagonists, pirenzepine and AF-DX 116, on passive avoidance tasks in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Heterogeneity of muscarinic autoreceptors and heteroreceptors in the rat brain: effects of a novel M1 agonist, AF102B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Human muscarinic receptors expressed in A9L and CHO cells: activation by full and partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Effect of centrally administered atropine and pirenzepine on radial arm maze performance in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarine receptor-mediated modulation of [3H]dopamine and [14C]acetylcholine release from rat neostriatal slices: selective antagonism by gallamine but not pirenzepine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Cholinergic receptor agonists inhibit pirenzepine-induced dysfunction of spontaneous alternation performance in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Functional effects of the muscarinic receptor agonist, xanomeline, at 5-HT1 and 5-HT2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Molecular biology of muscarinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Dopamine-acetylcholine interaction in the striatum studied by microdialysis in the awake rat: some methodological aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Differential effects of M1- and M2-muscarinic drugs on striatal dopamine release and metabolism in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Muscarinic m4 receptor activation by some atypical antipsychotic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Clozapine is a potent and selective muscarinic M4 receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

Cholinergic mechanism in brain inhibiting amphetamine-induced stereotyped behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

7 January 2021

inferred from DOI database lookup

The interaction of neuroleptic and muscarinic agents with central dopaminergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

7 January 2021

inferred from DOI database lookup

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903692-2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0006-8993(02)03692-2

1 reference

1 November 2017

1 reference